Donald M. Arnold, MD, MSc; Mark A. Crowther, MD, MSc
Potential Financial Conflicts of Interest: Dr. Arnold has received a grant from Hoffman-LaRoche, Canada, for the conduct of a clinical trial of rituximab in ITP.
Donald M. Arnold, Mark A. Crowther. Rituximab for Patients with Idiopathic Thrombocytopenic Purpura. Ann Intern Med. 2007;147:281–282. doi: 10.7326/0003-4819-147-4-200708210-00019
Download citation file:
Published: Ann Intern Med. 2007;147(4):281-282.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use